Significant Gaps in Vaccine Uptake, Trust for US Adults
An NFID initiative provided evidence-based guidance on influenza, COVID-19, and RSV during the 2025-2026 season.
Tag: vaccine COVID-19
All
Latest
Significant Gaps in Vaccine Uptake, Trust for US Adults
An NFID initiative provided evidence-based guidance on influenza, COVID-19, and RSV during the 2025-2026 season.
Read More
HCWs Report Fewer Side Effects from Protein-based COVID-19 Vaccine
A survey of frontline healthcare workers suggests a protein-based COVID-19 vaccine may cause fewer symptoms and less work disruption compared to mRNA options.
Read More
Court Blocks HHS Revisions to Child Vaccine Schedule
A US district court blocked HHS Secretary Robert Kennedy Jr’s recent moves to revise the federal childhood vaccine schedule and overhaul of the CDC’s vaccine advisory board, according to multiple media reports including Reuters.
Read More
Natural Fungal Supplement Improved COVID-19 Vaccine Response
Participants with no prior exposure to SARS-CoV-2 experienced fewer vaccine side effects and continued increases in antibody levels over six months.
Read More
‘Messy’ Nanoparticles May Deliver Drugs Better
New research suggests that messier, less-stuffed nanoparticles may actually deliver drugs more effectively than tightly packed ones.
Read More
Faster, Safer Vaccine Development
Virus-like systems safely replicate key features of pathogens like SARS-CoV-2, enabling faster vaccine and antiviral testing in standard biosafety level 2 labs.
Read More
COVID-19 Booster Reduced Hospitalizations, Mortality Risks
Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million UK adults who had the autumn 2022 vaccine.
Read More
COVID-19 Vaccination During Pregnancy Reduced Preeclampsia Risk
COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia.
Read More
Researchers ID Cause of Blood Clots After COVID Vaccines, Infections
Scientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving certain COVID‑19 vaccines, or after natural adenovirus infection.
Read More
42% of Adults 50+ Skipped Flu and COVID-19 Vaccinations
Vaccination against influenza and COVID-19 currently lags among people 50 and older, according to a national survey.
Read More
AAP Issues Immunization Schedule for 2026
The 2026 AAP recommendations remain largely unchanged from 2025 but differ from the CDC’s new immunization schedule.
Read More
CDC/HHS Remove Vaccines from Childhood Immunization Schedule
The CDC and HHS reduced the federally recommended childhood immunization schedule from 17 to 11 vaccinations, removing shots for seasonal flu and other infectious diseases.
Read MoremRNA Vaccine Components Work Together to Produce Immunity
The mRNA and lipid nanoparticles that deliver it actively stimulate the immune system and work together to produce germinal centers and immune protection.
Read More
COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema
COVID-19 vaccinated children had significantly fewer infections, including pneumonia, bronchitis, bronchiolitis, sinusitis, upper respiratory infections, and more.
Read More
Cancer Survival Benefits for Patients Receiving mRNA-based COVID-19 Vaccines
Commercially available mRNA COVID-19 vaccines can train patients’ immune systems to eliminate cancer, according to data presented at ESMO 2025.
Read More
COVID-19 Vaccination During Pregnancy Safe and Beneficial for Mother, Infant
COVID-19 vaccination is associated with better neonatal outcomes without added maternal risk, according to an analysis of data from over 1.2 million pregnancies.
Read More
CDC Panel Changes Guidance on COVID-19 Vaccines
The US CDC’s Advisory Committee on Immunization Practices (ACIP) issued guidance on COVID-19 vaccination recommending “shared clinical decision-making.”
Read MorePositive Topline Data for Comirmaty LP.8.1 COVID-19 Vaccine
Preliminary data show the Comirnaty COVID-19 vaccine increases neutralizing antibodies targeting the LP.8.1 sublineage of SARS-CoV-2.
Read More
Polarization Around Vaccine Hesitancy 12x Greater During Pandemic
Political polarization during COVID-19 was 12 times greater than in past disease outbreaks in terms of vaccine hesitancy.
Read More
CDC Predicts Possibility of Higher COVID-19 Hospitalizations for 2025-26 Season
CDC’s annual respiratory disease season outlook predicts similar peak hospitalization rates for COVID-19, influenza and RSV — but a higher hospitalization rate for COVID-19 if a new variant emerges.
Read MoreFDA Approves Comirnaty COVID-19 Vaccine
The FDA approved Pfizer/BioNTech’s Comirnaty LP.8.1 COVID-19 vaccine for adults age 65+ and those age 5-64 years old with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.
Read More
AAP Publishes Its Own Vaccine Recommendations
The American Academy of Pediatrics published its pediatric immunization recommendations for influenza, RSV, and COVID-19, which differ from some recommendations made by the FDA.
Read More
Cost-effectiveness of Broad COVID-19 Vaccinations
Public health experts advocate for broad COVID-19 vaccinations for adults over age 65 not only for the clinical benefits but the financial savings as well.
Read MoreHHS Defunds mRNA Vaccine Development Projects
HHS Secretary Robert F. Kennedy, Jr says mRNA vaccines fail to protect effectively against upper respiratory infections like COVID and flu.
Read More